A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3? pathway.

Liu W, Yao Y, Shi L, Tang G, Wu L. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3? pathway. J Cell Biochem. 2021 10; 122(10):1302-1312.

View in: PubMed

subject areas

Apoptosis
Case-Control Studies
Cell Cycle
Cell Proliferation
Gene Expression Regulation, Neoplastic
Humans
Leukoplakia, Oral
Mouth Mucosa
Mouth Neoplasms
Prognosis
Proto-Oncogene Proteins c-akt
Survival Rate
Tumor Cells, Cultured

authors with profiles

Lang Wu, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support